Method for sequencing a polynucleotide template

• US 20090093378A1
• Filed: 08/28/2008
• Published: 04/09/2009
• Est. Priority Date: 08/29/2007
• Status: Abandoned Application

• Current Assignee: Illumina Cambridge Limited (Illumina Incorporated)
• Original Assignee: Illumina Cambridge Limited (Illumina Incorporated)
• Inventors: Bignell, Helen, Smith, Geoffrey, West, John Stephen, Hims, Matthew, Gormley, Niall Anthony
• Application Number:
  US12/231,052
• Publication Number:
  US 20090093378A1
• Time in Patent Office: Days
• US Class Current: 506/23
• CPC Class Codes: C12N 15/1093 General methods of preparing gene libraries, not provided for in other subgroups
• CPC Class Codes: C12Q 1/6869 Methods for sequencing
• CPC Class Codes: C12Q 2525/307 Circular oligonucleotides

Abstract

The invention relates to methods for pairwise sequencing of a double-stranded polynucleotide template, which methods result in the sequential determination of nucleotide sequences in two distinct and separate regions of the polynucleotide template.

Claims

1. A method for producing a library of 3′

and 5′

modified nucleic acids suitable for paired end sequencing comprising;

a. fragmenting a primary double stranded nucleic acid target sequence to produce a first population of linear nucleic acid target fragments with blunt ends;

b. self-ligating the blunt ends of the linear nucleic acid target fragments to form circular constructs;

c. treating the circular constructs to reduce the ratio of linear fragments to circular constructs;

d. fragmenting the circular constructs to produce a second population of linear fragments, a percentage of which comprises two ends from each of the first population of linear target fragments;

e. ligating adapter sequences to the 3′ and

5′

ends of the second population of linear fragments to produce a library of 3′ and

5′

modified nucleic acids suitable for paired end sequencing.

2. The method according to claim 1, wherein said linear nucleic acid target fragments with blunt ends are generated by shearing and enzymatic end repair with a nucleic acid polymerase and nucleotide triphosphates.

3. The method according to claim 1, wherein said linear nucleic acid target fragments with blunt ends are generated by random primer amplification of the primary double stranded nucleic acid target sequence.

4. The method according to claim 3, wherein the random primer amplification is performed using random primers comprising a ligand.

5. The method according to claim 4, wherein the ligand is biotin.

6. The method according to claim 2, wherein at least one of the nucleoside triphosphates comprises a modification allowing selection of end repaired fragments.

7. The method according to claim 6, wherein the modification is biotin.

8. The method according to claim 1, wherein the treating the circular constructs to reduce the ratio of linear fragments to circular constructs comprises exonuclease treatment.

9. The method according to claim 8, wherein the exonuclease is DNase.

10. The method according to claim 1, wherein the treating the circular constructs to reduce the ratio of linear fragments to circular constructs comprises rolling circle amplification of the circular constructs.

11. The method according to claim 1, wherein the library of 3′

and 5′

modified nucleic acids is amplified in solution using amplification primers complementary to the adapter sequences.

12. The method according to claim 11, wherein the amplification primers are complementary to the adapter sequences and further comprise a single stranded sequence of nucleotides that extends beyond the 5′

end of the adapter sequences.

13. The method according to claim 5 or 7, wherein biotinylated sequences are generated and isolated from non biotinylated sequences using avidin or streptavidin beads.

14. The method according to claim 1, wherein the self-ligating the blunt ends of the linear nucleic acid target fragments to form circular constructs comprises ligase treatment.

15. The method according to claim 14, wherein the ligase is T3 ligase.

16. The method according to claim 1, wherein the primary double stranded nucleic acid target sequence is cDNA or genomic DNA or a subset thereof.

17. The method of claim 16, wherein the genomic DNA or the subset thereof is human genomic DNA or a subset of human genomic DNA.

18. The method of claim 16, wherein the subset of genomic DNA is a chromosome.

19. The method of claim 1, wherein the fragmenting the primary double stranded nucleic acid target sequence to produce the first population of linear nucleic acid target fragments with blunt ends is random fragmenting.

20. The method of claim 1, wherein the fragmenting the primary double stranded nucleic acid target sequence to produce the first population of linear nucleic acid target fragments with blunt ends comprises enzymatic, chemical or mechanical treatment.